Home » InVitro Fertilization (IVF) Market
InVitro Fertilization (IVF) Market
Published date: Apr 2022 •Formats:
Request Sample Schedule a Call

Global InVitro Fertilization (IVF) Market By Type (Intrauterine Insemination (IUI), Intra Cytoplasmic Sperm Injection (ICSI), Drug and Hormone Therapies, Other), By Application (Male Infertility, Female Infertility), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028

  • Published date: Apr 2022
  • Report ID: 24946
  • Number of Pages: 239
  • Format:
  • keyboard_arrow_up
    • 1. Global InVitro Fertilization (IVF) Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global InVitro Fertilization (IVF) Market Overview
      • 3.1. Global InVitro Fertilization (IVF) Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global InVitro Fertilization (IVF) Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global InVitro Fertilization (IVF) Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Intrauterine Insemination (IUI)
      • 4.4. Intra Cytoplasmic Sperm Injection (ICSI)
      • 4.5. Drug and Hormone Therapies
      • 4.6. Other
    • 5. Global InVitro Fertilization (IVF) Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global InVitro Fertilization (IVF) Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Male Infertility
      • 5.4. Female Infertility
    • 6. Global InVitro Fertilization (IVF) Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Global InVitro Fertilization (IVF) Market: Regional Trend Analysis
          • 6.1.1. 1.US
          • 6.1.1. 2.Canada
          • 6.1.1. 3.Mexico
      • 6.2. Europe
        • 6.2.1. Europe Global InVitro Fertilization (IVF) Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Global InVitro Fertilization (IVF) Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4.India
          • 6.3.1.5.Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Global InVitro Fertilization (IVF) Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Global InVitro Fertilization (IVF) Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global InVitro Fertilization (IVF) Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Vitrolife AB
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Merck Serono
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Ferring Pharmaceuticals
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Irvine Scientific
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. GeneaBiomedx
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Cooper Surgical
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. Origio
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10. Genea
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. Halotech Dna
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
      • 7.12. Auxilium Pharmaceuticals
        • 7.12.1. Company Overview
        • 7.12.2. Financial Highlights
        • 7.12.3. Product Portfolio
        • 7.12.4. SWOT Analysis
        • 7.12.5. Key Strategies and Developments
      • 7.13. Auxogyn
        • 7.13.1. Company Overview
        • 7.13.2. Financial Highlights
        • 7.13.3. Product Portfolio
        • 7.13.4. SWOT Analysis
        • 7.13.5. Key Strategies and Developments
      • 7.14. Ovascience
        • 7.14.1. Company Overview
        • 7.14.2. Financial Highlights
        • 7.14.3. Product Portfolio
        • 7.14.4. SWOT Analysis
        • 7.14.5. Key Strategies and Developments
      • 7.15. Andrology Solutions
        • 7.15.1. Company Overview
        • 7.15.2. Financial Highlights
        • 7.15.3. Product Portfolio
        • 7.15.4. SWOT Analysis
        • 7.15.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
    • Vitrolife AB
    • Merck Serono
    • Ferring Pharmaceuticals
    • Irvine Scientific
    • GeneaBiomedx
    • Cooper Surgical
    • Origio
    • Genea
    • Halotech Dna
    • Auxilium Pharmaceuticals
    • Auxogyn
    • Ovascience
    • Andrology Solutions
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

InVitro Fertilization (IVF) Market
  • 24946
  • Apr 2022
    • ★★★★★
      ★★★★★
    • (96)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
Find Help
Legal
Explore